Thursday, 25 July 2019

Prevagen maker must face FTC, New York claims that memory supplement does not work

Quincy Bioscience failed to dismiss a lawsuit in which the Federal Trade Commission and New York attorney general said it deceptively marketed the dietary supplement Prevagen by claiming it improved memory despite a lack of scientific evidence.


No comments:

Post a Comment